These findings were supported by our gene expression analysis on EMT and CRC stem cell marker genes in downregulated NR1D1 cells, where the expression of SNAI1 and CD44 were significantly downregulated compared to the control cells (Figure S3B). This evidence concerns the gene NR1D1 and colorectal carcinoma.